As one of the leading companies for the contract manufacturing of biopharmaceuticals, Boehringer Ingelheim offers the entire production technology chain in development and production at its facilities in Biberach (Germany) and Vienna (Austria). The large scale manufacturing sites deliver biopharmaceutical products like therapeutic proteins, fusion proteins, protein scaffolds, monoclonal antibodies, antibody mimetics and plasmid DNA.
The Biberach site is specialized in highly efficient mammalian cell culture systems with yields well above industry standard. The Austria site offers high-expression in bacteria and yeast with exceptionally high productivities using proprietary systems. In the plasmid DNA manufacturing arena, Boehringer Ingelheim in Austria has set the standard, and supplies early to late-stage clinical trials with gene-therapeutics and DNA vaccines for its international clients.
Our customers benefit from a track record of 15 launched biopharmaceutical products, which have been developed and produced in our state-of the art facilities following our one-stop-shop concept. By designing tailor-made solutions, a collaboration with Boehringer Ingelheim is an attractive strategic option for our world wide partners who want to speed up product development while minimizing investment risk.
Our contract development and manufacturing strategy is made up of flexible modules covering the entire process chain from cell line development to fill and finish.
Locations
Boehringer Ingelheim Pharma GmbH & Co. KG
Birkendorfer Str. 65
Biberach,
Germany,
Europe
GMP Experience
The facility in Biberach is Europe's largest biopharmaceutical plant for the contract development and manufacture of therapeutic proteins from mammalian cell cultures.
Boehringer Ingelheim RCV GmbH & Co KG
Dr. Boehringer Gasse 5-11
Vienna,
Austria,
Europe
GMP Experience
The facility in Vienna produces therapeutically active proteins from micro-organisms and yeast with state-of-the-art fermentation technologies.
Boehringer Ingelheim Pharma GmbH & Co. KG
Biberach Train 1
Location: Biberach, Germany

Drug Substance (API)

Cell Culture

Batch

Fed-Batch

15000L Bioreactor

Commercial

Biosafety Level 1

Analytical Services

Cell Banking

Cell Line Development

Preclinical Manufacturing

Viral Manufacturing
Availability:
Contact CMO
Last Update:
09JUN10
Boehringer Ingelheim Pharma GmbH & Co. KG
Biberach Train 2
Location: Biberach, Germany

Drug Substance (API)

Cell Culture

Batch

Fed-Batch

15000L Bioreactor

Phase III

Biosafety Level 1

Analytical Services

Cell Banking

Cell Line Development

Preclinical Manufacturing

Viral Manufacturing
Availability:
Contact CMO
Last Update:
09JUN10
Boehringer Ingelheim Pharma GmbH & Co. KG
Biberach Train 3
Location: Biberach, Germany

Drug Substance (API)

Cell Culture

Batch

Fed-Batch

2000L Bioreactor

Commercial

Biosafety Level 1

Analytical Services

Cell Banking

Cell Line Development

Preclinical Manufacturing

Viral Manufacturing
Availability:
Contact CMO
Last Update:
09JUN10
Boehringer Ingelheim Pharma GmbH & Co. KG
Biberach Train 4
Location: Biberach, Germany

Drug Substance (API)

Cell Culture

Batch

Fed-Batch

2000L Bioreactor

Phase III

Biosafety Level 1

Analytical Services

Cell Banking

Cell Line Development

Preclinical Manufacturing

Viral Manufacturing
Availability:
Contact CMO
Last Update:
09JUN10
Boehringer Ingelheim Pharma GmbH & Co. KG
Biberach Train 5
Location: Biberach, Germany

Drug Substance (API)

Cell Culture

Batch

Fed-Batch

2000L Bioreactor

Phase I/II

Biosafety Level 1

Analytical Services

Cell Banking

Cell Line Development

Preclinical Manufacturing

Viral Manufacturing
Availability:
Contact CMO
Last Update:
09JUN10
Boehringer Ingelheim Pharma GmbH & Co. KG
Biberach Train 6
Location: Biberach, Germany

Drug Substance (API)

Cell Culture

Batch

Fed-Batch

400L Bioreactor

Phase III

Biosafety Level 1

Analytical Services

Cell Banking

Cell Line Development

Preclinical Manufacturing

Viral Manufacturing
Availability:
Contact CMO
Last Update:
09JUN10
Boehringer Ingelheim Pharma GmbH & Co. KG
Biberach Train 7
Location: Biberach, Germany

Drug Substance (API)

Cell Culture

Batch

Fed-Batch

400L Bioreactor

Phase I/II

Biosafety Level 1

Analytical Services

Cell Banking

Cell Line Development

Preclinical Manufacturing

Viral Manufacturing
Availability:
Contact CMO
Last Update:
09JUN10
Boehringer Ingelheim RCV GmbH & Co KG
Vienna Microbial Train 1
Location: Vienna, Austria

Drug Substance (API)

Microbial

Batch

Fed-Batch

6000L Bioreactor

Commercial

Biosafety Level 1

Analytical Services

Cell Banking

Cell Line Development

Preclinical Manufacturing

Viral Manufacturing
Availability:
Contact CMO
Last Update:
09JUN10
Boehringer Ingelheim RCV GmbH & Co KG
Vienna Microbial Train 2
Location: Vienna, Austria

Drug Substance (API)

Microbial

Batch

Fed-Batch

6000L Bioreactor

Phase III

Biosafety Level 1

Analytical Services

Cell Banking

Cell Line Development

Preclinical Manufacturing

Viral Manufacturing
Availability:
Contact CMO
Last Update:
09JUN10
Boehringer Ingelheim RCV GmbH & Co KG
Vienna Microbial Train 3
Location: Vienna, Austria

Drug Substance (API)

Microbial

Batch

Fed-Batch

6000L Bioreactor

Phase I/II

Biosafety Level 1

Analytical Services

Cell Banking

Cell Line Development

Preclinical Manufacturing

Viral Manufacturing
Availability:
Contact CMO
Last Update:
09JUN10
Boehringer Ingelheim RCV GmbH & Co KG
Vienna Microbial Train 4
Location: Vienna, Austria

Drug Substance (API)

Microbial

Batch

Fed-Batch

300L Bioreactor

Commercial

Biosafety Level 1

Analytical Services

Cell Banking

Cell Line Development

Preclinical Manufacturing

Viral Manufacturing
Availability:
Contact CMO
Last Update:
09JUN10
Boehringer Ingelheim RCV GmbH & Co KG
Vienna Microbial Train 5
Location: Vienna, Austria

Drug Substance (API)

Microbial

Batch

Fed-Batch

300L Bioreactor

Phase III

Biosafety Level 1

Analytical Services

Cell Banking

Cell Line Development

Preclinical Manufacturing

Viral Manufacturing
Availability:
Contact CMO
Last Update:
09JUN10
Boehringer Ingelheim RCV GmbH & Co KG
Vienna Microbial Train 6
Location: Vienna, Austria

Drug Substance (API)

Microbial

Batch

Fed-Batch

300L Bioreactor

Phase I/II

Biosafety Level 1

Analytical Services

Cell Banking

Cell Line Development

Preclinical Manufacturing

Viral Manufacturing
Availability:
Contact CMO
Last Update:
09JUN10
Boehringer Ingelheim Pharma GmbH & Co. KG
Biberach Fill/Finish Pilot Line 1
Location: Biberach, Germany

Drug Product (Fill/Finish)

Liquid

20,000-50,000

2 ml

3 ml

5 ml

10 ml

20 ml

20+ ml

Phase III

Not Specified

Analytical Services

Formulation Development

Preclinical Manufacturing

Stability Studies

Prefilled Syringes

Viral Manufacturing
Availability:
Contact CMO
Last Update:
09JUN10
Boehringer Ingelheim Pharma GmbH & Co. KG
Biberach Fill/Finish Pilot Line 2
Location: Biberach, Germany

Drug Product (Fill/Finish)

Liquid

20,000-50,000

2 ml

3 ml

5 ml

10 ml

20 ml

20+ ml

Phase I/II

Not Specified

Analytical Services

Formulation Development

Preclinical Manufacturing

Stability Studies

Prefilled Syringes

Viral Manufacturing
Availability:
Contact CMO
Last Update:
09JUN10
Boehringer Ingelheim Pharma GmbH & Co. KG
Biberach Fill/Finish Pilot Line 3
Location: Biberach, Germany

Drug Product (Fill/Finish)

Liquid

5,000-20,000

2 ml

10 ml

Phase III

Not Specified

Analytical Services

Formulation Development

Preclinical Manufacturing

Stability Studies

Prefilled Syringes

Viral Manufacturing
Availability:
Contact CMO
Last Update:
09JUN10
Boehringer Ingelheim Pharma GmbH & Co. KG
Biberach Fill/Finish Pilot Line 4
Location: Biberach, Germany

Drug Product (Fill/Finish)

Liquid

5,000-20,000

2 ml

10 ml

Phase I/II

Not Specified

Analytical Services

Formulation Development

Preclinical Manufacturing

Stability Studies

Prefilled Syringes

Viral Manufacturing
Availability:
Contact CMO
Last Update:
09JUN10
Boehringer Ingelheim Pharma GmbH & Co. KG
Biberach Fill/Finish Pilot Line 5
Location: Biberach, Germany

Drug Product (Fill/Finish)

Lyophilized

5,000-20,000

2 ml

3 ml

5 ml

10 ml

20 ml

20+ ml

Phase III

Not Specified

Analytical Services

Formulation Development

Preclinical Manufacturing

Stability Studies

Prefilled Syringes

Viral Manufacturing
Availability:
Contact CMO
Last Update:
09JUN10
Boehringer Ingelheim Pharma GmbH & Co. KG
Biberach Fill/Finish Pilot Line 6
Location: Biberach, Germany

Drug Product (Fill/Finish)

Lyophilized

5,000-20,000

2 ml

3 ml

5 ml

10 ml

20 ml

20+ ml

Phase I/II

Not Specified

Analytical Services

Formulation Development

Preclinical Manufacturing

Stability Studies

Prefilled Syringes

Viral Manufacturing
Availability:
Contact CMO
Last Update:
09JUN10
Boehringer Ingelheim Pharma GmbH & Co. KG
Biberach Fill/Finish Pilot Line 7
Location: Biberach, Germany

Drug Product (Fill/Finish)

Lyophilized

5,000-20,000

3 ml

Phase III

Not Specified

Analytical Services

Formulation Development

Preclinical Manufacturing

Stability Studies

Prefilled Syringes

Viral Manufacturing
Availability:
Contact CMO
Last Update:
09JUN10
Boehringer Ingelheim Pharma GmbH & Co. KG
Biberach Fill/Finish Pilot Line 8
Location: Biberach, Germany

Drug Product (Fill/Finish)

Lyophilized

5,000-20,000

3 ml

Phase I/II

Not Specified

Analytical Services

Formulation Development

Preclinical Manufacturing

Stability Studies

Prefilled Syringes

Viral Manufacturing
Availability:
Contact CMO
Last Update:
09JUN10
Boehringer Ingelheim Pharma GmbH & Co. KG
Biberach Fill/Finish Pilot Line 9
Location: Biberach, Germany

Drug Product (Fill/Finish)

Liquid

5,000-20,000

3 ml

Phase III

Not Specified

Analytical Services

Formulation Development

Preclinical Manufacturing

Stability Studies

Prefilled Syringes

Viral Manufacturing
Availability:
Contact CMO
Last Update:
09JUN10
Boehringer Ingelheim Pharma GmbH & Co. KG
Biberach Fill/Finish Pilot Line 10
Location: Biberach, Germany

Drug Product (Fill/Finish)

Liquid

5,000-20,000

3 ml

Phase I/II

Not Specified

Analytical Services

Formulation Development

Preclinical Manufacturing

Stability Studies

Prefilled Syringes

Viral Manufacturing
Availability:
Contact CMO
Last Update:
09JUN10
Boehringer Ingelheim Pharma GmbH & Co. KG
Biberach Fill/Finish Line 1
Location: Biberach, Germany

Drug Product (Fill/Finish)

Liquid

5,000-20,000

2 ml

3 ml

5 ml

10 ml

20 ml

20+ ml

Commercial

Not Specified

Analytical Services

Formulation Development

Preclinical Manufacturing

Stability Studies

Prefilled Syringes

Viral Manufacturing
Availability:
Contact CMO
Last Update:
09JUN10
Boehringer Ingelheim Pharma GmbH & Co. KG
Biberach Fill/Finish Line 2
Location: Biberach, Germany

Drug Product (Fill/Finish)

Liquid

20,000-50,000

2 ml

3 ml

5 ml

10 ml

20 ml

20+ ml

Commercial

Not Specified

Analytical Services

Formulation Development

Preclinical Manufacturing

Stability Studies

Prefilled Syringes

Viral Manufacturing
Availability:
Contact CMO
Last Update:
09JUN10
Boehringer Ingelheim Pharma GmbH & Co. KG
Biberach Fill/Finish Line 3
Location: Biberach, Germany

Drug Product (Fill/Finish)

Liquid

50,000+

2 ml

3 ml

5 ml

10 ml

Commercial

Not Specified

Analytical Services

Formulation Development

Preclinical Manufacturing

Stability Studies

Prefilled Syringes

Viral Manufacturing
Availability:
Contact CMO
Last Update:
09JUN10
Boehringer Ingelheim Pharma GmbH & Co. KG
Biberach Fill/Finish Line 4
Location: Biberach, Germany

Drug Product (Fill/Finish)

Liquid

50,000+

2 ml

3 ml

5 ml

10 ml

20 ml

20+ ml

Commercial

Not Specified

Analytical Services

Formulation Development

Preclinical Manufacturing

Stability Studies

Prefilled Syringes

Viral Manufacturing
Availability:
Contact CMO
Last Update:
09JUN10